32750-26-8 Usage
Nitrophenol derivative
A class of organic compounds This compound belongs to the nitrophenol class, which contains both a nitro group (-NO2) and a phenolic hydroxyl group.
Tert-butyl group
A type of alkyl group The compound features a tert-butyl group (a specific type of alkyl group) attached to the benzene ring.
Iodine atom
A halogen element The presence of an iodine atom in the compound provides unique properties and reactivity.
Nitro group
A functional group with -NO2 The compound contains a nitro group, which may contribute to its potential toxicity.
Hydroxyl group
A functional group with -OH The presence of a hydroxyl group on the benzene ring influences the compound's reactivity and properties.
Benzene ring
Aromatic structure The compound's core structure is a benzene ring, which is an aromatic and stable arrangement of carbon and hydrogen atoms.
Potential applications
Organic chemistry, pharmaceuticals, and chemical products 2-(tert-butyl)-6-iodo-4-nitrophenol has possible uses in various fields, including the synthesis of pharmaceuticals and other chemical products.
Toxicity
Caution required in handling and usage Due to the presence of a nitro group, this compound may have some toxicity, and it should be handled with care in laboratory or industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 32750-26-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,7,5 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 32750-26:
(7*3)+(6*2)+(5*7)+(4*5)+(3*0)+(2*2)+(1*6)=98
98 % 10 = 8
So 32750-26-8 is a valid CAS Registry Number.
32750-26-8Relevant articles and documents
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability
Randolph, John T.,Krueger, A. Chris,Donner, Pamela L.,Pratt, John K.,Liu, Dachun,Motter, Christopher E.,Rockway, Todd W.,Tufano, Michael D.,Wagner, Rolf,Lim, Hock B.,Beyer, Jill M.,Mondal, Rubina,Panchal, Neeta S.,Colletti, Lynn,Liu, Yaya,Koev, Gennadiy,Kati, Warren M.,Hernandez, Lisa E.,Beno, David W. A.,Longenecker, Kenton L.,Stewart, Kent D.,Dumas, Emily O.,Molla, Akhteruzzaman,Maring, Clarence J.
, p. 1153 - 1163 (2018/02/17)
ABT-072 is a non-nucleoside HCV NS5B polymerase inhibitor that was discovered as part of a program to identify new direct-acting antivirals (DAAs) for the treatment of HCV infection. This compound was identified during a medicinal chemistry effort to impr
ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF
-
Page/Page column 98; 108, (2009/04/25)
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
